Related Experiment Video
Updated: Jun 21, 2026
08:44
A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Congenital and acquired polycythemias
Fabian P Siegel1, Petro E Petrides
1Hematology Oncology Center Munich, Zweibrückenstrasse 2, Munich, Germany.
Deutsches Arzteblatt International
|July 28, 2009
Summary
Polycythemia involves elevated red blood cells, with Polycythemia Vera (PV) being a key acquired stem cell disorder. Understanding erythropoietin signaling and JAK2 mutations is crucial for diagnosis and management.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Polycythemias are conditions marked by an increased concentration of red blood cells.
- These disorders frequently present to non-hematologic physicians due to routine blood cell counts.
- Polycythemia vera (PV) is the most significant acquired stem cell variant.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and management of polycythemias.
- To highlight the role of erythropoietin and its receptor system.
- To differentiate between congenital and acquired forms of polycythemia.
Main Methods:
- Selective literature review.
- Incorporation of authors' clinical experiences.
Main Results:
- Erythropoietin and its receptor system are critical in polycythemia.
- Congenital polycythemias stem from genetic mutations (Erythropoietin-receptor gene, hemoglobin variants, 2,3-BPGM deficiency) or renal oxygen sensing issues.
- Acquired polycythemias result from hypoxia, JAK2 mutations, or pulmonary/renal diseases; artificial erythrocytosis is seen in doping.
Conclusions:
- Differential diagnosis involves erythropoietin levels, JAK2 mutation analysis, and hemoglobin electrophoresis.
- Polycythemia vera demands immediate treatment due to high thromboembolic risk.
- Epidemiological studies on polycythemias in German-speaking regions are needed.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...